nodes	percent_of_prediction	percent_of_DWPC	metapath
Phosphatidylserine—PTDSS2—myometrium—ovarian cancer	0.0123	0.026	CbGeAlD
Phosphatidylserine—SCARB1—embryo—ovarian cancer	0.0116	0.0246	CbGeAlD
Phosphatidylserine—DGKD—myometrium—ovarian cancer	0.0114	0.0241	CbGeAlD
Phosphatidylserine—PISD—myometrium—ovarian cancer	0.0112	0.0237	CbGeAlD
Phosphatidylserine—SMPD4—gonad—ovarian cancer	0.00987	0.0209	CbGeAlD
Phosphatidylserine—SMPD4—uterus—ovarian cancer	0.00981	0.0208	CbGeAlD
Phosphatidylserine—SCARB1—epithelium—ovarian cancer	0.00947	0.0201	CbGeAlD
Phosphatidylserine—PTDSS1—female reproductive system—ovarian cancer	0.00912	0.0193	CbGeAlD
Phosphatidylserine—PTDSS2—decidua—ovarian cancer	0.00911	0.0193	CbGeAlD
Phosphatidylserine—SCARB1—decidua—ovarian cancer	0.00894	0.019	CbGeAlD
Phosphatidylserine—DGKD—uterine cervix—ovarian cancer	0.00885	0.0188	CbGeAlD
Phosphatidylserine—SMPD4—female reproductive system—ovarian cancer	0.00882	0.0187	CbGeAlD
Phosphatidylserine—SMPD3—female gonad—ovarian cancer	0.00877	0.0186	CbGeAlD
Phosphatidylserine—SMPD3—vagina—ovarian cancer	0.00872	0.0185	CbGeAlD
Phosphatidylserine—PISD—uterine cervix—ovarian cancer	0.00871	0.0185	CbGeAlD
Phosphatidylserine—PTDSS2—endometrium—ovarian cancer	0.00865	0.0183	CbGeAlD
Phosphatidylserine—PTDSS1—bone marrow—ovarian cancer	0.00861	0.0182	CbGeAlD
Phosphatidylserine—ATP8A1—female gonad—ovarian cancer	0.0086	0.0182	CbGeAlD
Phosphatidylserine—DGKD—decidua—ovarian cancer	0.00843	0.0179	CbGeAlD
Phosphatidylserine—DGKG—testis—ovarian cancer	0.0083	0.0176	CbGeAlD
Phosphatidylserine—PISD—decidua—ovarian cancer	0.0083	0.0176	CbGeAlD
Phosphatidylserine—PTDSS1—female gonad—ovarian cancer	0.00829	0.0176	CbGeAlD
Phosphatidylserine—SMPD4—female gonad—ovarian cancer	0.00802	0.017	CbGeAlD
Phosphatidylserine—PTDSS2—gonad—ovarian cancer	0.00802	0.017	CbGeAlD
Phosphatidylserine—DGKD—endometrium—ovarian cancer	0.008	0.017	CbGeAlD
Phosphatidylserine—PISD—endometrium—ovarian cancer	0.00788	0.0167	CbGeAlD
Phosphatidylserine—SCARB1—gonad—ovarian cancer	0.00787	0.0167	CbGeAlD
Phosphatidylserine—SMPD3—testis—ovarian cancer	0.00778	0.0165	CbGeAlD
Phosphatidylserine—ATP8A1—testis—ovarian cancer	0.00763	0.0162	CbGeAlD
Phosphatidylserine—DGKD—gonad—ovarian cancer	0.00742	0.0157	CbGeAlD
Phosphatidylserine—DGKD—uterus—ovarian cancer	0.00737	0.0156	CbGeAlD
Phosphatidylserine—PISD—uterus—ovarian cancer	0.00726	0.0154	CbGeAlD
Phosphatidylserine—PTDSS2—female reproductive system—ovarian cancer	0.00716	0.0152	CbGeAlD
Phosphatidylserine—SMPD4—testis—ovarian cancer	0.00712	0.0151	CbGeAlD
Phosphatidylserine—SCARB1—female reproductive system—ovarian cancer	0.00703	0.0149	CbGeAlD
Phosphatidylserine—DGKD—female reproductive system—ovarian cancer	0.00663	0.0141	CbGeAlD
Phosphatidylserine—PISD—female reproductive system—ovarian cancer	0.00653	0.0138	CbGeAlD
Phosphatidylserine—PTDSS2—female gonad—ovarian cancer	0.00652	0.0138	CbGeAlD
Phosphatidylserine—PTDSS2—vagina—ovarian cancer	0.00648	0.0137	CbGeAlD
Phosphatidylserine—SCARB1—female gonad—ovarian cancer	0.0064	0.0136	CbGeAlD
Phosphatidylserine—PRKCA—embryo—ovarian cancer	0.0064	0.0136	CbGeAlD
Phosphatidylserine—DGKD—bone marrow—ovarian cancer	0.00626	0.0133	CbGeAlD
Phosphatidylserine—PISD—bone marrow—ovarian cancer	0.00616	0.0131	CbGeAlD
Phosphatidylserine—DGKD—female gonad—ovarian cancer	0.00603	0.0128	CbGeAlD
Phosphatidylserine—DGKG—lymph node—ovarian cancer	0.00602	0.0128	CbGeAlD
Phosphatidylserine—DGKD—vagina—ovarian cancer	0.006	0.0127	CbGeAlD
Phosphatidylserine—PISD—female gonad—ovarian cancer	0.00594	0.0126	CbGeAlD
Phosphatidylserine—PISD—vagina—ovarian cancer	0.0059	0.0125	CbGeAlD
Phosphatidylserine—PTDSS2—testis—ovarian cancer	0.00578	0.0123	CbGeAlD
Phosphatidylserine—SCARB1—testis—ovarian cancer	0.00568	0.012	CbGeAlD
Phosphatidylserine—SMPD3—lymph node—ovarian cancer	0.00564	0.012	CbGeAlD
Phosphatidylserine—ATP8A1—lymph node—ovarian cancer	0.00553	0.0117	CbGeAlD
Phosphatidylserine—DGKD—testis—ovarian cancer	0.00535	0.0113	CbGeAlD
Phosphatidylserine—PISD—testis—ovarian cancer	0.00527	0.0112	CbGeAlD
Phosphatidylserine—PRKCA—epithelium—ovarian cancer	0.00522	0.0111	CbGeAlD
Phosphatidylserine—SMPD4—lymph node—ovarian cancer	0.00516	0.0109	CbGeAlD
Phosphatidylserine—PRKCA—decidua—ovarian cancer	0.00493	0.0105	CbGeAlD
Phosphatidylserine—PRKCA—gonad—ovarian cancer	0.00434	0.0092	CbGeAlD
Phosphatidylserine—PRKCA—uterus—ovarian cancer	0.00431	0.00914	CbGeAlD
Phosphatidylserine—PTDSS2—lymph node—ovarian cancer	0.00419	0.00888	CbGeAlD
Phosphatidylserine—SCARB1—lymph node—ovarian cancer	0.00411	0.00872	CbGeAlD
Phosphatidylserine—DGKD—lymph node—ovarian cancer	0.00388	0.00822	CbGeAlD
Phosphatidylserine—PRKCA—female reproductive system—ovarian cancer	0.00388	0.00822	CbGeAlD
Phosphatidylserine—PISD—lymph node—ovarian cancer	0.00382	0.0081	CbGeAlD
Phosphatidylserine—PRKCA—female gonad—ovarian cancer	0.00353	0.00748	CbGeAlD
Phosphatidylserine—PRKCA—testis—ovarian cancer	0.00313	0.00663	CbGeAlD
Phosphatidylserine—PRKCA—lymph node—ovarian cancer	0.00227	0.00481	CbGeAlD
Phosphatidylserine—PRKCA—Insulin Signaling—AKT1—ovarian cancer	9.69e-05	0.000183	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—IL6—ovarian cancer	9.69e-05	0.000183	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—IL6—ovarian cancer	9.69e-05	0.000183	CbGpPWpGaD
Phosphatidylserine—PRKCA—Downstream signal transduction—AKT1—ovarian cancer	9.64e-05	0.000182	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—IL6—ovarian cancer	9.6e-05	0.000182	CbGpPWpGaD
Phosphatidylserine—PRKCA—EGF/EGFR Signaling Pathway—AKT1—ovarian cancer	9.59e-05	0.000182	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—AKT1—ovarian cancer	9.59e-05	0.000182	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—AKT1—ovarian cancer	9.55e-05	0.000181	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—IL6—ovarian cancer	9.52e-05	0.00018	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—AKT1—ovarian cancer	9.5e-05	0.00018	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—IL6—ovarian cancer	9.47e-05	0.000179	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—IL6ST—ovarian cancer	9.47e-05	0.000179	CbGpPWpGaD
Phosphatidylserine—SMPD4—Metabolism—AKT1—ovarian cancer	9.46e-05	0.000179	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—STAT3—ovarian cancer	9.45e-05	0.000179	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—NRAS—ovarian cancer	9.42e-05	0.000178	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—VEGFA—ovarian cancer	9.4e-05	0.000178	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—VEGFA—ovarian cancer	9.4e-05	0.000178	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	9.36e-05	0.000177	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—STAT3—ovarian cancer	9.3e-05	0.000176	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—STAT3—ovarian cancer	9.3e-05	0.000176	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—YAP1—ovarian cancer	9.3e-05	0.000176	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—NRAS—ovarian cancer	9.28e-05	0.000176	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—NRAS—ovarian cancer	9.28e-05	0.000176	CbGpPWpGaD
Phosphatidylserine—PRKCA—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.18e-05	0.000174	CbGpPWpGaD
Phosphatidylserine—PRKCA—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.16e-05	0.000173	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FASN—ovarian cancer	9.05e-05	0.000171	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—MAPK3—ovarian cancer	9.03e-05	0.000171	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PARP1—ovarian cancer	9.01e-05	0.000171	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—ovarian cancer	8.96e-05	0.00017	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—AKT1—ovarian cancer	8.94e-05	0.000169	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—AKT1—ovarian cancer	8.94e-05	0.000169	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—MAPK3—ovarian cancer	8.89e-05	0.000168	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—MAPK3—ovarian cancer	8.89e-05	0.000168	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CD—ovarian cancer	8.89e-05	0.000168	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—AKT1—ovarian cancer	8.86e-05	0.000168	CbGpPWpGaD
Phosphatidylserine—PRKCA—M Phase—MAPK3—ovarian cancer	8.81e-05	0.000167	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HDAC6—ovarian cancer	8.79e-05	0.000166	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—AKT1—ovarian cancer	8.78e-05	0.000166	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neuronal System—MAPK1—ovarian cancer	8.76e-05	0.000166	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—AKT1—ovarian cancer	8.74e-05	0.000165	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PPP2R1A—ovarian cancer	8.67e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	8.66e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—SMPD3—Metabolism—AKT1—ovarian cancer	8.65e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—PTDSS2—Metabolism—AKT1—ovarian cancer	8.65e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—MYC—ovarian cancer	8.64e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—MYC—ovarian cancer	8.64e-05	0.000164	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—SLC2A1—ovarian cancer	8.6e-05	0.000163	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—MAPK1—ovarian cancer	8.59e-05	0.000163	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—EGFR—ovarian cancer	8.59e-05	0.000163	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—ovarian cancer	8.58e-05	0.000162	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—MAPK1—ovarian cancer	8.46e-05	0.00016	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—MAPK1—ovarian cancer	8.46e-05	0.00016	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—EGFR—ovarian cancer	8.45e-05	0.00016	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—EGFR—ovarian cancer	8.45e-05	0.00016	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.41e-05	0.000159	CbGpPWpGaD
Phosphatidylserine—PRKCA—M Phase—MAPK1—ovarian cancer	8.38e-05	0.000159	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	8.29e-05	0.000157	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—KRAS—ovarian cancer	8.11e-05	0.000154	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—MYC—ovarian cancer	8.09e-05	0.000153	CbGpPWpGaD
Phosphatidylserine—PRKCA—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	8.07e-05	0.000153	CbGpPWpGaD
Phosphatidylserine—PTDSS1—Metabolism—AKT1—ovarian cancer	8.04e-05	0.000152	CbGpPWpGaD
Phosphatidylserine—PISD—Metabolism—AKT1—ovarian cancer	8.04e-05	0.000152	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CD—ovarian cancer	8e-05	0.000151	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—KRAS—ovarian cancer	7.99e-05	0.000151	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—KRAS—ovarian cancer	7.99e-05	0.000151	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PPP2R1A—ovarian cancer	7.92e-05	0.00015	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—ovarian cancer	7.92e-05	0.00015	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—PPP2R1A—ovarian cancer	7.87e-05	0.000149	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—YAP1—ovarian cancer	7.78e-05	0.000147	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CB—ovarian cancer	7.75e-05	0.000147	CbGpPWpGaD
Phosphatidylserine—PRKCA—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	7.68e-05	0.000145	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	7.67e-05	0.000145	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—XIAP—ovarian cancer	7.62e-05	0.000144	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—FASN—ovarian cancer	7.58e-05	0.000143	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism of mRNA—AKT1—ovarian cancer	7.54e-05	0.000143	CbGpPWpGaD
Phosphatidylserine—PRKCA—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.48e-05	0.000142	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—SLC5A5—ovarian cancer	7.46e-05	0.000141	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—PIK3CA—ovarian cancer	7.45e-05	0.000141	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SMARCA4—ovarian cancer	7.42e-05	0.000141	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—PIK3CA—ovarian cancer	7.34e-05	0.000139	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—PIK3CA—ovarian cancer	7.34e-05	0.000139	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CCND1—ovarian cancer	7.32e-05	0.000139	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PPP2R1A—ovarian cancer	7.31e-05	0.000138	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EREG—ovarian cancer	7.25e-05	0.000137	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—PIK3CA—ovarian cancer	7.23e-05	0.000137	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—SLC2A1—ovarian cancer	7.2e-05	0.000136	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—IL2—ovarian cancer	7.11e-05	0.000135	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—TP53—ovarian cancer	7.1e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—TP53—ovarian cancer	7.1e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—ERBB2—ovarian cancer	7.07e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CD8A—ovarian cancer	7.06e-05	0.000134	CbGpPWpGaD
Phosphatidylserine—PRKCA—Neuronal System—HRAS—ovarian cancer	7.03e-05	0.000133	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—MTOR—ovarian cancer	6.97e-05	0.000132	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CB—ovarian cancer	6.97e-05	0.000132	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CYP1B1—ovarian cancer	6.9e-05	0.000131	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—HRAS—ovarian cancer	6.89e-05	0.000131	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDKN1B—ovarian cancer	6.86e-05	0.00013	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—HRAS—ovarian cancer	6.79e-05	0.000129	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PGR—ovarian cancer	6.79e-05	0.000129	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—HRAS—ovarian cancer	6.79e-05	0.000129	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—IL6—ovarian cancer	6.6e-05	0.000125	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CCND1—ovarian cancer	6.54e-05	0.000124	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CDKN1B—ovarian cancer	6.54e-05	0.000124	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—IL6—ovarian cancer	6.5e-05	0.000123	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—IL6—ovarian cancer	6.5e-05	0.000123	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism of RNA—AKT1—ovarian cancer	6.45e-05	0.000122	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CG—ovarian cancer	6.39e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PARP1—ovarian cancer	6.31e-05	0.000119	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CTNNB1—ovarian cancer	6.18e-05	0.000117	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PPP2R1A—ovarian cancer	6.12e-05	0.000116	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—AKT1—ovarian cancer	6.09e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—VEGFA—ovarian cancer	6.04e-05	0.000114	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL6ST—ovarian cancer	6.04e-05	0.000114	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—MAPK3—ovarian cancer	6.04e-05	0.000114	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PTEN—ovarian cancer	6.03e-05	0.000114	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—AKT1—ovarian cancer	5.99e-05	0.000113	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—AKT1—ovarian cancer	5.99e-05	0.000113	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—NRAS—ovarian cancer	5.97e-05	0.000113	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—AKT1—ovarian cancer	5.9e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—MYC—ovarian cancer	5.87e-05	0.000111	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TERT—ovarian cancer	5.81e-05	0.00011	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CG—ovarian cancer	5.8e-05	0.00011	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—TLR4—ovarian cancer	5.75e-05	0.000109	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—MAPK1—ovarian cancer	5.74e-05	0.000109	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—MAPK3—ovarian cancer	5.72e-05	0.000108	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—ABCB1—ovarian cancer	5.69e-05	0.000108	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CD—ovarian cancer	5.62e-05	0.000106	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—AKT1—ovarian cancer	5.61e-05	0.000106	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—TYMS—ovarian cancer	5.58e-05	0.000106	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—ESR1—ovarian cancer	5.58e-05	0.000106	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL6ST—ovarian cancer	5.52e-05	0.000104	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—MAPK1—ovarian cancer	5.44e-05	0.000103	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MAPK3—ovarian cancer	5.4e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—NRAS—ovarian cancer	5.38e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CAV1—ovarian cancer	5.37e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MYC—ovarian cancer	5.25e-05	9.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—MAPK3—ovarian cancer	5.15e-05	9.74e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—KRAS—ovarian cancer	5.14e-05	9.73e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MAPK1—ovarian cancer	5.13e-05	9.72e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PPP2R1A—ovarian cancer	5.12e-05	9.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CD—ovarian cancer	5.1e-05	9.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—IL6ST—ovarian cancer	5.09e-05	9.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—MAPK1—ovarian cancer	4.9e-05	9.27e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—EGFR—ovarian cancer	4.9e-05	9.27e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CB—ovarian cancer	4.89e-05	9.27e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—APC—ovarian cancer	4.89e-05	9.26e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CDH1—ovarian cancer	4.88e-05	9.23e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CA—ovarian cancer	4.72e-05	8.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—CXCL8—ovarian cancer	4.7e-05	8.9e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CD—ovarian cancer	4.66e-05	8.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—KRAS—ovarian cancer	4.63e-05	8.76e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—TP53—ovarian cancer	4.57e-05	8.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CAV1—ovarian cancer	4.5e-05	8.52e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—IL2—ovarian cancer	4.5e-05	8.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CB—ovarian cancer	4.44e-05	8.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—HRAS—ovarian cancer	4.37e-05	8.27e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—TP53—ovarian cancer	4.31e-05	8.16e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CD—ovarian cancer	4.3e-05	8.14e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—CXCL8—ovarian cancer	4.27e-05	8.09e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CA—ovarian cancer	4.25e-05	8.05e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—ERBB2—ovarian cancer	4.12e-05	7.79e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CG—ovarian cancer	4.1e-05	7.76e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL2—ovarian cancer	4.08e-05	7.73e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TERT—ovarian cancer	4.07e-05	7.7e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MTOR—ovarian cancer	4.06e-05	7.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CB—ovarian cancer	4.06e-05	7.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—HRAS—ovarian cancer	3.93e-05	7.44e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—AKT1—ovarian cancer	3.86e-05	7.3e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CDKN1B—ovarian cancer	3.81e-05	7.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERBB2—ovarian cancer	3.8e-05	7.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—IL6—ovarian cancer	3.76e-05	7.12e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CAV1—ovarian cancer	3.76e-05	7.12e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CB—ovarian cancer	3.75e-05	7.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MTOR—ovarian cancer	3.75e-05	7.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL2—ovarian cancer	3.73e-05	7.06e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ESR1—ovarian cancer	3.63e-05	6.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CD—ovarian cancer	3.6e-05	6.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CTNNB1—ovarian cancer	3.6e-05	6.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL6ST—ovarian cancer	3.57e-05	6.75e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CDKN1B—ovarian cancer	3.52e-05	6.66e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PTEN—ovarian cancer	3.51e-05	6.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—AKT1—ovarian cancer	3.47e-05	6.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CG—ovarian cancer	3.43e-05	6.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—APC—ovarian cancer	3.43e-05	6.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—NRAS—ovarian cancer	3.43e-05	6.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CTNNB1—ovarian cancer	3.32e-05	6.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—MAPK3—ovarian cancer	3.28e-05	6.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTEN—ovarian cancer	3.24e-05	6.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CB—ovarian cancer	3.14e-05	5.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—STAT3—ovarian cancer	3.14e-05	5.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—NRAS—ovarian cancer	3.13e-05	5.93e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—MAPK1—ovarian cancer	3.12e-05	5.91e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—EGFR—ovarian cancer	3.12e-05	5.91e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CD—ovarian cancer	3.01e-05	5.7e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MAPK3—ovarian cancer	3e-05	5.68e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CA—ovarian cancer	2.98e-05	5.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—MAPK3—ovarian cancer	2.98e-05	5.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—KRAS—ovarian cancer	2.95e-05	5.58e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—MYC—ovarian cancer	2.9e-05	5.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—STAT3—ovarian cancer	2.9e-05	5.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—NRAS—ovarian cancer	2.89e-05	5.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MAPK1—ovarian cancer	2.85e-05	5.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EGFR—ovarian cancer	2.85e-05	5.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MAPK3—ovarian cancer	2.77e-05	5.24e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTEN—ovarian cancer	2.71e-05	5.14e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CA—ovarian cancer	2.71e-05	5.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—KRAS—ovarian cancer	2.69e-05	5.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MYC—ovarian cancer	2.69e-05	5.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ERBB2—ovarian cancer	2.66e-05	5.04e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MAPK1—ovarian cancer	2.63e-05	4.99e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EGFR—ovarian cancer	2.63e-05	4.99e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CB—ovarian cancer	2.63e-05	4.97e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MTOR—ovarian cancer	2.63e-05	4.97e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CXCL8—ovarian cancer	2.52e-05	4.78e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—HRAS—ovarian cancer	2.51e-05	4.75e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—KRAS—ovarian cancer	2.49e-05	4.71e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CA—ovarian cancer	2.48e-05	4.69e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CDKN1B—ovarian cancer	2.46e-05	4.66e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—AKT1—ovarian cancer	2.44e-05	4.61e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CASP3—ovarian cancer	2.42e-05	4.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL2—ovarian cancer	2.41e-05	4.56e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL6—ovarian cancer	2.4e-05	4.54e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CCND1—ovarian cancer	2.35e-05	4.45e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CTNNB1—ovarian cancer	2.33e-05	4.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—HRAS—ovarian cancer	2.29e-05	4.34e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CA—ovarian cancer	2.29e-05	4.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MMP9—ovarian cancer	2.28e-05	4.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTEN—ovarian cancer	2.27e-05	4.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—AKT1—ovarian cancer	2.21e-05	4.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL6—ovarian cancer	2.19e-05	4.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HRAS—ovarian cancer	2.11e-05	4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—VEGFA—ovarian cancer	2.05e-05	3.88e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—STAT3—ovarian cancer	2.03e-05	3.84e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NRAS—ovarian cancer	2.02e-05	3.83e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—IL6—ovarian cancer	2.02e-05	3.83e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—AKT1—ovarian cancer	2.02e-05	3.83e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—AKT1—ovarian cancer	2.01e-05	3.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MAPK3—ovarian cancer	1.94e-05	3.67e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CA—ovarian cancer	1.91e-05	3.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MYC—ovarian cancer	1.89e-05	3.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—AKT1—ovarian cancer	1.87e-05	3.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MAPK1—ovarian cancer	1.84e-05	3.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EGFR—ovarian cancer	1.84e-05	3.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KRAS—ovarian cancer	1.74e-05	3.3e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CA—ovarian cancer	1.6e-05	3.03e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—AKT1—ovarian cancer	1.56e-05	2.96e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TP53—ovarian cancer	1.55e-05	2.93e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HRAS—ovarian cancer	1.48e-05	2.8e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL6—ovarian cancer	1.42e-05	2.68e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—AKT1—ovarian cancer	1.31e-05	2.48e-05	CbGpPWpGaD
